Palbace 100 mg Capsule
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Palbace 100 mg Capsule

Palbace 100 mg Capsule

Palbace 100 mg Capsule contains palbociclib, a targeted anticancer medicine used to treat certain hormone receptor-positive, HER2-negative breast cancers. It works by inhibiting CDK4 and CDK6 proteins that help cancer cells divide and grow. The capsule is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Category

Palbace 100 mg Capsule contains 100 mg of palbociclib and is formulated for oral administration. It is used in combination with endocrine therapy for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. The prescribed regimen generally involves taking palbociclib once daily for 21 consecutive days followed by 7 days without treatment. Regular blood-count monitoring is required during therapy because palbociclib can cause decreased blood cell counts.

Technical Specification

Specification Details
Active Ingredient Palbociclib 100 mg
Dosage Form Hard Capsule
Therapeutic Class Cyclin-Dependent Kinase Inhibitor
Main Indication HR-Positive, HER2-Negative Breast Cancer
Route of Administration Oral
Strength 100 mg

Product Also Known As

Palbace 100 mg Capsule, Palbace 100 mg, Palbociclib 100 mg Capsule, Palbociclib 100 mg, Palbociclib Hard Capsule, Palbociclib Breast Cancer Capsule